Executive Director
Keros Therapeutics
Francis Wolenski PhD DABT Fellow ATS is an Executive Director at Keros Therapeutics. He oversees the design and implementation of pre-clinical and clinical Bioanalytical testing strategies, and additionally is responsible for Toxicology and Translational Science functions. Francis is a long-time member of the American College of Toxicology and joined AAPS years ago to broaden his understanding of drug development.
Disclosure information not submitted.
Rapid Fire: Breaking Barriers: Bioanalytical Innovation for Complex Biologics
Monday, May 5, 2025
2:30 PM - 3:30 PM ET
Hot Topic: Industry Discussions on Companion Diagnostics for AAV-Mediated Gene Therapy
Tuesday, May 6, 2025
10:00 AM - 11:00 AM ET